{
    "clinical_study": {
        "@rank": "124240", 
        "arm_group": [
            {
                "arm_group_label": "tDCS + robotic arm therapy", 
                "arm_group_type": "Experimental", 
                "description": "Transcranial Direct Current Stimulation (tDCS) 2mA for 20 minutes over the primary motor cortex (M1) in the affected hemisphere followed by robotic arm therapy for 60 minutes, 3x per week for 12 weeks"
            }, 
            {
                "arm_group_label": "tDCS sham  + robotic arm therapy", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Transcranial Direct Current Stimulation sham condition (0 mA) for 20 minutes over the primary motor cortex (M1) in the affected hemisphere followed by robotic arm therapy for 60 minutes, 3x per week for 12 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate if multiple therapy sessions of Transcranial Direct\n      Current Stimulation (tDCS non-invasive brain stimulation) combined with robotic arm therapy\n      lead to a greater functional recovery in upper limb mobility after stroke than that provided\n      by robotic arm therapy alone."
        }, 
        "brief_title": "Robots Paired With tDCS in Stroke Recovery", 
        "completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Stroke", 
        "condition_browse": {
            "mesh_term": [
                "Stroke", 
                "Cerebral Infarction"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18 years of age or older\n\n          -  First single focal unilateral lesion with diagnosis verified by brain imaging, which\n             occurred at least 6 months prior\n\n          -  Cognitive function sufficient enough to understand experiments and follow\n             instructions\n\n          -  Fugl-Meyer assessment of 7 to 58 out of 66 (neither hemiplegic nor fully recovered\n             motor function in the muscles of the shoulder, elbow, and wrist)\n\n        Exclusion Criteria:\n\n          -  Botox treatment within 6 weeks of enrollment\n\n          -  Fixed contraction of the affected limb\n\n          -  Complete flaccid paralysis of the affected limb\n\n          -  History of hemorrhagic stroke\n\n          -  Ongoing use of CNS active medications\n\n          -  Ongoing use of psychoactive medications\n\n          -  Presence of additional potential tDCS/TMS risk factors including damaged skin at site\n             of stimulation, presence of a magnetically/mechanically active implant, metal in the\n             head, family history of epilepsy, and personal history of seizures"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "66", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 26, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01726673", 
            "org_study_id": "12-102B"
        }, 
        "intervention": [
            {
                "arm_group_label": "tDCS + robotic arm therapy", 
                "intervention_name": "Transcranial Direct Current Stimulation (tDCS)", 
                "intervention_type": "Device", 
                "other_name": [
                    "tDCS", 
                    "Low intensity transcranial DC stimulator", 
                    "Soterix 1x1"
                ]
            }, 
            {
                "arm_group_label": "tDCS sham  + robotic arm therapy", 
                "intervention_name": "Placebo sham", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Stroke", 
            "Cerebrovascular Accident", 
            "Cerebral Stroke", 
            "CVA", 
            "Robotic therapy", 
            "Upper extremity recovery", 
            "tDCS", 
            "Non-invasive brain stimulation"
        ], 
        "lastchanged_date": "January 21, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Manhasset", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "11030"
                }, 
                "name": "Feinstein Institute for Medical Research"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effects of Transcranial Direct Current Stimulation Paired With Robotic Arm Therapy on Recovery of Upper Extremity Motor Function in Stroke Patients", 
        "overall_contact": {
            "email": "bvolpe1@nshs.edu", 
            "last_name": "Bruce T Volpe, MD", 
            "phone": "516-562-3384"
        }, 
        "overall_contact_backup": {
            "email": "jchang14@nshs.edu", 
            "last_name": "Johanna Chang, MS", 
            "phone": "(516) 562-3646"
        }, 
        "overall_official": {
            "affiliation": "Feinstein Institute for Medical Research", 
            "last_name": "Bruce T Volpe, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change from baseline in Upper Extremity Fugl Meyer Assessment", 
            "safety_issue": "No", 
            "time_frame": "12 weeks (immediately following the intervention) and 36 weeks (6 months after the intervention)"
        }, 
        "reference": {
            "PMID": "19531875", 
            "citation": "Edwards DJ, Krebs HI, Rykman A, Zipse J, Thickbroom GW, Mastaglia FL, Pascual-Leone A, Volpe BT. Raised corticomotor excitability of M1 forearm area following anodal tDCS is sustained during robotic wrist therapy in chronic stroke. Restor Neurol Neurosci. 2009;27(3):199-207."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01726673"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Kinematic Data of upper extremity mobility as measure by Interactive Motion Technologies planar (shoulder/elbow) robot and wrist (wrist flexion/extension and pronation/supination) robots during therapy and evaluations", 
                "measure": "Change from baseline in Kinematic Data", 
                "safety_issue": "No", 
                "time_frame": "12 weeks (immediately following the intervention) and 36 weeks (6 months after the intervention)"
            }, 
            {
                "measure": "Change from baseline in WOLF motor function test", 
                "safety_issue": "No", 
                "time_frame": "12 weeks (immediately following the intervention) and 36 weeks (6 months after the intervention)"
            }, 
            {
                "measure": "Change from baseline in Motor Power Manual Muscle Test", 
                "safety_issue": "No", 
                "time_frame": "12 weeks (immediately following the intervention) and 36 weeks (6 months after the intervention)"
            }, 
            {
                "measure": "Change from baseline in NIH stroke scale", 
                "safety_issue": "No", 
                "time_frame": "12 weeks (immediately following the intervention) and 36 weeks (6 months after the intervention)"
            }, 
            {
                "measure": "Change from baseline in Stroke Impact Scale (SIS)", 
                "safety_issue": "No", 
                "time_frame": "12 weeks (immediately following the intervention) and 36 weeks (6 months after the intervention)"
            }
        ], 
        "source": "North Shore Long Island Jewish Health System", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "North Shore Long Island Jewish Health System", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}